Evolution of the Pseudomonas aeruginosa quorum-sensing hierarchy M Kostylev, DY Kim, NE Smalley, I Salukhe, EP Greenberg, AA Dandekar Proceedings of the National Academy of Sciences 116 (14), 7027-7032, 2019 | 234 | 2019 |
CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells K Petri, W Zhang, J Ma, A Schmidts, H Lee, JE Horng, DY Kim, IC Kurt, ... Nature biotechnology 40 (2), 189-193, 2022 | 143 | 2022 |
Maternal consumption of ultra-processed foods and subsequent risk of offspring overweight or obesity: results from three prospective cohort studies Y Wang, K Wang, M Du, N Khandpur, SL Rossato, CH Lo, H VanEvery, ... BMJ 379, 2022 | 55 | 2022 |
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito WT Garrood, N Kranjc, K Petri, DY Kim, JA Guo, AM Hammond, ... Proceedings of the National Academy of Sciences 118 (22), e2004838117, 2021 | 37 | 2021 |
The mental health burden of racial and ethnic minorities during the COVID-19 pandemic LH Nguyen, A Anyane-Yeboa, K Klaser, J Merino, DA Drew, W Ma, ... PloS one 17 (8), e0271661, 2022 | 33 | 2022 |
Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects K Petri, DY Kim, KE Sasaki, MC Canver, X Wang, H Shah, H Lee, ... bioRxiv, 2021 | 22 | 2021 |
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation E Konstantinidis, A Molisak, F Perrin, L Streubel-Gallasch, S Fayad, ... Molecular Therapy-Nucleic Acids 28, 450-461, 2022 | 21 | 2022 |
Racial Differences in Genomic Profiles of Breast Cancer N Goel*, DY Kim*, JA Guo, D Zhao, BA Mahal, M Alshalalfa JAMA Network Open 5 (3), e220573-e220573, 2022 | 18 | 2022 |
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection JA Guo, HI Hoffman, SG Shroff, P Chen, PG Hwang, DY Kim, DW Kim, ... Clinical cancer research 27 (10), 2807-2815, 2021 | 15 | 2021 |
Pan-Cancer Survival Classification With Clinicopathological and Targeted Gene Expression Features D Zhao*, DY Kim*, P Chen*, P Yu, S Ho, SW Cheng, C Zhao, JA Guo, ... Cancer Informatics 20, 11769351211035137, 2021 | 6 | 2021 |
Disease flare in patients with dermatomyositis following COVID-19 vaccination CX Pan, N Goldman, DY Kim, R Rowley, M Schaefer, AH LaChance, ... Journal of the American Academy of Dermatology 87 (6), 1373-1374, 2022 | 4 | 2022 |
Cutaneous immune‐related adverse events from immune checkpoint inhibitor therapy: Moving beyond “maculopapular rash” BS Allais, CJ Fay, DY Kim, YR Semenov, NR LeBoeuf Immunological Reviews 318 (1), 22-36, 2023 | 3 | 2023 |
Nicotinamide for Skin-Cancer Chemoprevention in Transplantation N Trepanowski, DY Kim, RI Hartman The New England journal of medicine 388 (26), 2493-2494, 2023 | 3 | 2023 |
Trends in hair, skin, and nails supplement use: Data from the National Health and Nutrition Examination Survey 2011-2020 N Trepanowski, KJ Moore, DY Kim, RI Hartman Journal of the American Academy of Dermatology 89 (1), 161-163, 2023 | 2 | 2023 |
DNA repair and immune checkpoint blockade response JA Guo*, M Alshalalfa*, DY Kim*, HI Hoffman, C Shiau, J Su, WL Hwang, ... Cancer Genetics, 2022 | 2 | 2022 |
Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells K Petri, W Zhang, J Ma, A Schmidts, H Lee, JE Horng, DY Kim, IC Kurt, ... Nature Biotechnology 40 (2), 273-273, 2022 | 2 | 2022 |
Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade using Tissue Cyclic Immunofluorescence: A Pilot Study Z Maliga, DY Kim, ATN Bui, JR Lin, AK Dewan, S Jadeja, GF Murphy, ... The Journal of investigative dermatology, S0022-202X (24) 00107-6, 2024 | 1 | 2024 |
Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation CX Pan, WC Lau, DY Kim, CB Lau, R Rowley, R Kanwar, NR LeBoeuf, ... Journal of the American Academy of Dermatology 89 (6), 1264-1268, 2023 | 1 | 2023 |
Incidence of In Situ and Invasive Cutaneous Melanomas During the COVID-19 Pandemic in the US DY Kim, RI Hartman JAMA dermatology 159 (10), 1141-1145, 2023 | 1 | 2023 |
Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010 to 2019 DY Kim, MA Marchetti, RI Hartman Journal of the American Academy of Dermatology 89 (3), 597-600, 2023 | 1 | 2023 |